Technology News and Research

RSS

First Edition: July 16, 2013

Kaiser Health News consumer columnist Michelle Andrews reports: "Since smokers' health-care costs tend to be higher than those of nonsmokers, is it reasonable for smokers to pay higher premiums when they buy insurance through the new state marketplaces that are scheduled to open in October? A handful of states and the District say the answer is no" (Andrews, 7/16).

16 Jul 2013

Researchers develop new test to detect E. coli at food processing facilities

Medical, agriculture and computer science researchers from the University of Alberta have teamed up to develop a test that will make Canadians feel safer about the meat they put on their tables.

16 Jul 2013

Discovery of hybrid cells in human melanoma

The University of Colorado Cancer Center along with Yale University and the Denver Crime Lab report in the journal PLOS ONE the first proof of cancer's ability to fuse with blood cells in a way that gives cancer the ability to travel, allowing previously stationary cancer cells to enter the bloodstream and seed sites of metastasis around the body.

16 Jul 2013

Law of physics can be demonstrated by collection of individual protein molecules

Experiments by biochemists at the University of California, Davis show for the first time that a law of physics, the ergodic theorem, can be demonstrated by a collection of individual protein molecules -- specifically, a protein that unwinds DNA. The work will be published online by the journal Nature on July 14.

16 Jul 2013

New application note describes ChIP assay technology for screening multiple epigenetic targets

Porvair Sciences has announced an application note describing the excellent results achievable from a new 96-well format version of its ChromaTrap chromatin immunoprecipitation assay technology.

From Chromatrap® - Porvair Sciences Ltd 16 Jul 2013

Use of electronic health records can reduce costs of outpatient care, says study

Use of electronic health records can reduce the costs of outpatient care by roughly 3 percent, compared to relying on traditional paper records.

16 Jul 2013

Conversation guide helps doctor tackle end-of-life care planning with patient

How does a doctor tackle the delicate issue of end-of-life care planning with a patient? With an aging population and people living longer with chronic illness, it is increasingly important for patients and family members to decide how they and their loved ones would like to spend their final days. And for physicians in both hospital and primary care settings, it is crucial that they know how to address this issue with sensitivity.

16 Jul 2013

Researchers distinguish viral and bacterial infections in children with fever

In children with fever but no other symptoms of illness, it is difficult to know whether a child has a viral infection that will resolve on its own or a potentially serious bacterial infection that requires antibiotics.

16 Jul 2013

Exalenz Bioscience launches BreathID Hp to test and treat H. pylori

Exalenz Bioscience, developer of advanced diagnostic systems that use a patient's breath to detect and help manage gastrointestinal and liver conditions, announced today the global launch of the BreathID Hp, a next generation device in the company's BreathID product line.

15 Jul 2013

Cambridge Epigenetix introduces TrueMethyl kits for epigenetics industry

Cambridge Epigenetix Ltd., a spin out biosciences company, has announced the launch of its TrueMethyl kits.

15 Jul 2013

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and BZL Biologics LLC, of New York, today announced an exclusive licensing and collaboration agreement for an antibody against PSMA-positive prostate cancers.

15 Jul 2013

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

We wanted to do something a bit different than the “typical” work on caffeine and exercise, and I have considerable interest in appetite regulation, so we built up from there.

15 Jul 2013

FDA approves QIAGEN’s therascreen EGFR test as companion diagnostic for NSCLC patients

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim's new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC in patients whose tumors have certain EGFR gene mutations.

From QIAGEN Manchester Limited 15 Jul 2013

Researchers use EEG signals for artifact suppression and brain wave extraction

Electroencephalography is a test to measure the electrical activity of the brain generated by scalp surface after being picked up by metal electrodes and conductive media. Proper classification of electroencephalography data is the main task in electroencephalography based brain computer interface.

15 Jul 2013

Ipsen closes acquisition of UK-based Syntaxin

Ipsen announced today the closing of the acquisition of Syntaxin, a UK-based private life sciences company specialized in botulinum toxin engineering.

15 Jul 2013

Natural tissue graft can spur regeneration of cartilage; improves symptoms in knee cartilage damaged patients

A natural tissue graft can spur regeneration of cartilage and improve symptoms in patients who have cartilage damage in their knee, according to a study by researchers from Hospital for Special Surgery.

15 Jul 2013

Mass. employer health insurance mandate repeal moves forward

Gov. Deval Patrick has agreed to end a state mandate that employers provide health insurance to their employees, included in Massachusetts' 2006 health care overhaul, because a federal law -- which is now delayed a year -- was set to impose a similar mandate on employers. The repeal is included in the 2014 budget.

15 Jul 2013

RXi Pharmaceuticals reports positive results from second Phase 1 study with RXI‑109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.

12 Jul 2013

Viewpoints: 'Implosion' of the ACA; Administration 'spin machine'; Republicans on 'search-and-destroy' mission

July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).

12 Jul 2013

Mitek Sports Medicine introduces HEALIX ADVANCE KNOTLESS Anchor with dual-thread technology

Mitek Sports Medicine, a leader in orthopaedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of the HEALIX ADVANCE KNOTLESS Anchor, a new suture anchor designed to provide optimal knotless fixation for rotator cuff repair.

12 Jul 2013

Technology News and Research

First Edition: July 16, 2013

Researchers develop new test to detect E. coli at food processing facilities

Discovery of hybrid cells in human melanoma

Law of physics can be demonstrated by collection of individual protein molecules

New application note describes ChIP assay technology for screening multiple epigenetic targets

Use of electronic health records can reduce costs of outpatient care, says study

Conversation guide helps doctor tackle end-of-life care planning with patient

Researchers distinguish viral and bacterial infections in children with fever

Exalenz Bioscience launches BreathID Hp to test and treat H. pylori

Cambridge Epigenetix introduces TrueMethyl kits for epigenetics industry

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

FDA approves QIAGEN’s therascreen EGFR test as companion diagnostic for NSCLC patients

Researchers use EEG signals for artifact suppression and brain wave extraction

Ipsen closes acquisition of UK-based Syntaxin

Natural tissue graft can spur regeneration of cartilage; improves symptoms in knee cartilage damaged patients

Mass. employer health insurance mandate repeal moves forward

RXi Pharmaceuticals reports positive results from second Phase 1 study with RXI‑109

Viewpoints: 'Implosion' of the ACA; Administration 'spin machine'; Republicans on 'search-and-destroy' mission

Mitek Sports Medicine introduces HEALIX ADVANCE KNOTLESS Anchor with dual-thread technology

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News